{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:55:26Z","timestamp":1783472126176,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11739-017-1774-x","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T23:44:56Z","timestamp":1513035896000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey"],"prefix":"10.1007","volume":"13","author":[{"given":"Chao-Feng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yuan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Hwai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"issue":"1","key":"1774_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1774_CR2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jjco\/hyh045","volume":"34","author":"AB Lowenfels","year":"2004","unstructured":"Lowenfels AB, Maisonneuve P (2004) Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 34(5):238\u2013244","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"1774_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2036.2006.02961.x","volume":"24","author":"Y Shaib","year":"2006","unstructured":"Shaib Y, Davila J, El-Serag H (2006) The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 24(1):87\u201394","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1774_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mc.20778","volume":"51","author":"PM Bracci","year":"2012","unstructured":"Bracci PM (2012) Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 51(1):53\u201363","journal-title":"Mol Carcinog"},{"key":"1774_CR5","unstructured":"Food N (2007) Physical activity, and the prevention of cancer: a global perspective. Washington, DC"},{"issue":"5","key":"1774_CR6","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505\u20131522","journal-title":"Am J Pathol"},{"issue":"1","key":"1774_CR7","first-page":"129","volume":"58","author":"D W\u0142odarek","year":"2007","unstructured":"W\u0142odarek D, Jerzy Podle\u015bny JS (2007) Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Roczniki Pa\u0144stwowego Zak\u0142adu 58(1):129","journal-title":"Roczniki Pa\u0144stwowego Zak\u0142adu"},{"issue":"4","key":"1774_CR8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56(4):952\u2013964","journal-title":"J Hepatol"},{"issue":"5","key":"1774_CR9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.mco.0000241677.40170.17","volume":"9","author":"M Machado","year":"2006","unstructured":"Machado M, Cortez-Pinto H (2006) Non-alcoholic steatohepatitis and metabolic syndrome. Curr Opin Clin Nutr Metab Care 9(5):637\u2013642","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"1774_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/13651820701286177","volume":"9","author":"HA Pitt","year":"2007","unstructured":"Pitt HA (2007) Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB 9(2):92\u201397","journal-title":"HPB"},{"issue":"8","key":"1774_CR11","first-page":"748","volume":"35","author":"G Targher","year":"2012","unstructured":"Targher G, Rossi A, Zamboni G, Fantin F, Antonioli A, Corzato F et al (2012) Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Investig 35(8):748","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"1774_CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","volume":"8","author":"MM Smits","year":"2011","unstructured":"Smits MM, van Geenen EJ (2011) The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8(3):169\u2013177","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"1774_CR13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jamcollsurg.2008.12.026","volume":"208","author":"A Mathur","year":"2009","unstructured":"Mathur A, Zyromski NJ, Pitt HA, Al-Azzawi H, Walker JJ, Saxena R et al (2009) Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg 208(5):989\u2013994","journal-title":"J Am Coll Surg"},{"issue":"5","key":"1774_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/ijms17050717","volume":"17","author":"C Sanna","year":"2016","unstructured":"Sanna C, Rosso C, Marietti M, Bugianesi E (2016) Non-alcoholic fatty liver disease and extra-hepatic cancers. Int J Mol Sci 17(5):717","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1774_CR15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MEG.0000000000000277","volume":"27","author":"L Saba","year":"2015","unstructured":"Saba L, di Martino M, Bosco S, del Monte M, de Cecco CN, Lombardo V et al (2015) MDCT classification of steatotic liver: a multicentric analysis. Eur J Gastroenterol Hepatol 27(3):290\u2013297","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"1774_CR16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2214\/AJR.09.2590","volume":"194","author":"CJ Boyce","year":"2010","unstructured":"Boyce CJ, Pickhardt PJ, Kim DH, Taylor AJ, Winter TC, Bruce RJ et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194(3):623\u2013628","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1774_CR17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1148\/radiol.10101233","volume":"258","author":"YS Park","year":"2011","unstructured":"Park YS, Park SH, Lee SS, Kim DY, Shin YM, Lee W et al (2011) Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 258(3):760\u2013766","journal-title":"Radiology"},{"issue":"24","key":"1774_CR18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2009.886","volume":"301","author":"D Li","year":"2009","unstructured":"Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML et al (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301(24):2553\u20132562","journal-title":"JAMA"},{"issue":"11","key":"1774_CR19","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s11605-010-1297-5","volume":"14","author":"CJ Balentine","year":"2010","unstructured":"Balentine CJ, Enriquez J, Fisher W, Hodges S, Bansal V, Sansgiry S et al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14(11):1832\u20131837","journal-title":"J Gastrointest Surg"},{"issue":"21","key":"1774_CR20","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1002\/cncr.25465","volume":"116","author":"RR McWilliams","year":"2010","unstructured":"McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, De Andrade M et al (2010) Obesity adversely affects survival in pancreatic cancer patients. Cancer 116(21):5054\u20135062","journal-title":"Cancer"},{"issue":"10","key":"1774_CR21","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/ijc.25240","volume":"127","author":"SH Olson","year":"2010","unstructured":"Olson SH, Chou JF, Ludwig E, O\u2019Reilly E, Allen PJ, Jarnagin WR et al (2010) Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 127(10):2412\u20132419","journal-title":"Int J Cancer"},{"issue":"5","key":"1774_CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1477-2574.2010.00178.x","volume":"12","author":"KC Fearon","year":"2010","unstructured":"Fearon KC, Baracos VE (2010) Cachexia in pancreatic cancer: new treatment options and measures of success. HPB 12(5):323\u2013324","journal-title":"HPB"},{"issue":"5","key":"1774_CR23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/1055-9965.EPI-05-0800","volume":"15","author":"AB Gonz\u00e1lez De","year":"2006","unstructured":"De Gonz\u00e1lez AB, Spencer EA, Bueno-de-Mesquita HB, Roddam A, Stolzenberg-Solomon R, Halkj\u00e6r J et al (2006) Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15(5):879\u2013885","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"1774_CR24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","volume":"39","author":"E-JM Geenen van","year":"2010","unstructured":"van Geenen E-JM, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ (2010) Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 39(8):1185\u20131190","journal-title":"Pancreas"},{"issue":"1","key":"1774_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11739-015-1346-x","volume":"11","author":"L Miele","year":"2016","unstructured":"Miele L, Gasbarrini G, Giorgio V, Gasbarrini A, Grieco A (2016) Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome. Intern Emerg Med 11(1):3\u201310","journal-title":"Intern Emerg Med"},{"issue":"4","key":"1774_CR26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2008.08.004","volume":"22","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin Endocrinol Metab 22(4):625\u2013638","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"18","key":"1774_CR27","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","volume":"92","author":"H Yu","year":"2000","unstructured":"Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92(18):1472\u20131489","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1774_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006676-200201000-00006","volume":"24","author":"Z Yao","year":"2002","unstructured":"Yao Z, Okabayashi Y, Yutsudo Y, Kitamura T, Ogawa W, Kasuga M (2002) Role of Akt in growth and survival of PANC-1 pancreatic cancer cells. Pancreas 24(1):42\u201346","journal-title":"Pancreas"},{"issue":"10","key":"1774_CR29","first-page":"2007","volume":"55","author":"U Bergmann","year":"1995","unstructured":"Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M (1995) Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55(10):2007\u20132011","journal-title":"Cancer Res"},{"issue":"6","key":"1774_CR30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/carcin\/bgn026","volume":"29","author":"W Liu","year":"2008","unstructured":"Liu W, Bloom DA, Cance WG, Kurenova EV, Golubovskaya VM, Hochwald SN (2008) FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis 29(6):1096\u20131107","journal-title":"Carcinogenesis"},{"issue":"15","key":"1774_CR31","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3748\/wjg.v16.i15.1854","volume":"16","author":"M Tomizawa","year":"2010","unstructured":"Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T (2010) Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer. World J Gastroenterol 16(15):1854\u20131858","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1774_CR32","first-page":"331","volume":"58","author":"T Muniraj","year":"2012","unstructured":"Muniraj T, Chari ST (2012) Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol 58(4):331","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"1","key":"1774_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mc.20771","volume":"51","author":"D Li","year":"2012","unstructured":"Li D (2012) Diabetes and pancreatic cancer. Mol Carcinog 51(1):64\u201374","journal-title":"Mol Carcinog"},{"issue":"1","key":"1774_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2009.12.021","volume":"209","author":"KD Salpea","year":"2010","unstructured":"Salpea KD, Humphries SE (2010) Telomere length in atherosclerosis and diabetes. Atherosclerosis 209(1):35\u201338","journal-title":"Atherosclerosis"},{"issue":"3","key":"1774_CR35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0002-9440(10)63460-8","volume":"163","author":"O Stoeltzing","year":"2003","unstructured":"Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD et al (2003) Regulation of hypoxia-inducible factor-1\u03b1, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol 163(3):1001\u20131011","journal-title":"Am J Pathol"},{"issue":"1","key":"1774_CR36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-291X(03)00107-4","volume":"302","author":"H Zeng","year":"2003","unstructured":"Zeng H, Datta K, Neid M, Li J, Parangi S, Mukhopadhyay D (2003) Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF\/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun 302(1):46\u201355","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"1774_CR37","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","volume":"294","author":"RZ Stolzenberg-Solomon","year":"2005","unstructured":"Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J et al (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294(22):2872\u20132878","journal-title":"JAMA"},{"issue":"4","key":"1774_CR38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","volume":"393","author":"S Iodice","year":"2008","unstructured":"Iodice S, Gandini S, Maisonneuve P, Lowenfels AB (2008) Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 393(4):535\u2013545","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"1774_CR39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jjco\/hyq185","volume":"41","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Nagata C, Wada K, Tamai Y, Tsuji M, Takatsuka N et al (2011) Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in Japan. Jpn J Clin Oncol 41(2):225\u2013231","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"1774_CR40","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","volume":"22","author":"MR Graaf","year":"2004","unstructured":"Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar H-J (2004) The risk of cancer in users of statins. J Clin Oncol 22(12):2388\u20132394","journal-title":"J Clin Oncol"},{"issue":"15","key":"1774_CR41","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","volume":"160","author":"L Blais","year":"2000","unstructured":"Blais L, Desgagn\u00e9 A, LeLorier J (2000) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 160(15):2363\u20132368","journal-title":"Arch Intern Med"},{"issue":"3","key":"1774_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-016-0717-6","volume":"27","author":"MS Simon","year":"2016","unstructured":"Simon MS, Desai P, Wallace R, Wu C, Howard BV, Martin LW et al (2016) Prospective analysis of association between statins and pancreatic cancer risk in the Women\u2019s Health Initiative. Cancer Causes Control 27(3):415\u2013423","journal-title":"Cancer Causes Control"},{"issue":"4","key":"1774_CR43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00280-011-1583-2","volume":"67","author":"S Shimoyama","year":"2011","unstructured":"Shimoyama S (2011) Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers. Cancer Chemother Pharmacol 67(4):729\u2013739","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"1774_CR44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","volume":"9","author":"MJ Thun","year":"2012","unstructured":"Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9(5):259\u2013267","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"1774_CR45","first-page":"4356","volume":"59","author":"MA Molina","year":"1999","unstructured":"Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59(17):4356\u20134362","journal-title":"Cancer Res"},{"issue":"7","key":"1774_CR46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jnci\/djh084","volume":"96","author":"EJ Jacobs","year":"2004","unstructured":"Jacobs EJ, Connell CJ, Rodriguez C, Patel AV, Calle EE, Thun MJ (2004) Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst 96(7):524\u2013528","journal-title":"J Natl Cancer Inst"},{"key":"1774_CR47","first-page":"5","volume-title":"Zhu R-T","author":"Y-P Zhang","year":"2015","unstructured":"Zhang Y-P, Wan Y-D, Sun Y-L, Li J (2015) Zhu R-T. A meta-analysis of observational studies. Sci Rep, Aspirin might reduce the incidence of pancreatic cancer, p 5"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-017-1774-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-017-1774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-017-1774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T11:38:53Z","timestamp":1520422733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-017-1774-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s11739-017-1774-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}